
Coniphage G 300mg/500mcg Tablet
Marketer
Coniak Lifesciences
Salt Composition
Gabapentin (300mg) + Methylcobalamin (500mcg)
Overview Coniphage G 300mg/500mcg Tablet
Gabapentin/Pregabalin 300mg/500mcg tablets offer combined relief from neuropathic pain. This dual-action formulation reduces pain signals by regulating nerve cell calcium channels. Administer orally, with or without food, ideally before sleep. Consistent daily timing ensures stable drug levels. Follow your physician's prescribed dosage and duration. If a dose is missed, take it immediately upon recall. Complete the entire course, regardless of symptom improvement. Abrupt cessation requires prior medical consultation. Potential side effects include nausea, swelling in the extremities, gait imbalance, vision blurring, fever, and involuntary eye movements (nystagmus). Dizziness and drowsiness may occur; avoid activities requiring alertness until the drug's effects are known. Report any unusual mood shifts, worsening depression, or suicidal ideation to your doctor. Disclose pregnancy, pregnancy plans, or breastfeeding before starting treatment. While generally compatible with other medications, interactions with certain drugs (including antacids and alcohol) can impact efficacy and increase adverse events.
Uses of Coniphage G 300mg/500mcg Tablet
Managing neuropathic pain
Major Benefits of Coniphage G 300mg/500mcg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Coniphage G 300mg/500mcg Tablets can be consumed with or without food, however, consistent timing is recommended.
Common Side effects of Coniphage G 300mg/500mcg Tablet:
- Dizziness
- Sleepiness
- Tiredness
- Uncoordinated body movements
How to use Coniphage G 300mg/500mcg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the 300mg/500mcg Coniphage G tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
How Coniphage G 300mg/500mcg Tablet works:
Coniphage G tablets (300mg Gabapentin/500mcg Methylcobalamin) combine gabapentin, an alpha-2-delta ligand that reduces pain signals by altering nerve cell calcium channel function, with methylcobalamin, a vitamin B12 derivative. Methylcobalamin promotes myelin production, protecting and repairing nerve fibers. This dual action effectively alleviates neuropathic pain.
SAFETY ADVICE
AlcoholUNSAFE
Taking Coniphage G 300mg/500mcg tablets with alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Use of Coniphage G 300mg/500mcg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against the risks before prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation and Coniphage G 300mg/500mcg tablets appear compatible. Available human data indicate minimal infant risk. Postnatal monitoring for sedation and increased weight is recommended.
DrivingUNSAFE
Taking Coniphage G 300mg/500mcg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Coniphage G 300mg/500mcg tablets. Dosage modification may be necessary; physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Coniphage G 300mg/500mcg Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Coniphage G 300mg/500mcg Tablet :
Should you forget to take a Coniphage G 300mg/500mcg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Coniphage G 300mg/500mcg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience |
